article thumbnail

STAT+: With big ambition — and a family name to match — Reed Jobs charts his own course in biotech

STAT

He was a sophomore studying biology at Stanford University and, up until October 2011, had always planned to pursue a career in cancer research. In the months after his father died of complications from pancreatic cancer, Reed Jobs found it difficult to go back to life as it was before.

361
361
article thumbnail

Opinion: The FDA’s risky action on compounding weight loss drugs

STAT

When Makena, a drug designed to prevent preterm births, hit the market in 2011 at $1,500 per dose, it drew rife backlash. The drug was based on an active ingredient that had been available for many years at a much lower cost.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

More than 70 babies have been born from uterus transplants: ‘It’s a complete new world’

STAT

The first successful transplant was performed in 2011 — but even then, the recipient wasn’t immediately able to get pregnant and deliver a baby. The first modern attempt at transferring a uterus from one human to another occurred at the turn of the millennium.

356
356
article thumbnail

STAT+: Documents detail how pharmacy giants Walgreens, CVS, and Walmart failed patients in the opioid epidemic

STAT

In 2011, Walgreens executives were under pressure. Amid a growing addiction crisis, and with the country already awash in prescription painkillers, the federal government was demanding accountability from the pharmacy giant for filling thousands of opioid prescriptions written by doctors in suspiciously large quantities.  

article thumbnail

Opinion: It’s time to rethink the Medicare annual wellness visit

STAT

In 2011, the Centers for Medicare and Medicaid Services created the annual wellness visit (AWV), a new visit type with no cost to Medicare patients, better reimbursement to primary care practices, and higher assigned credit for clinicians’ work.

324
324
article thumbnail

Why AstraZeneca’s CEO is accusing British tabloids of ‘fake news’

STAT

Damian here with news of a 2021-sized biotech round that has echoes of 2011, plus an ESMO recap and a curious stock move. Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Good morning, everyone. Read the rest…

article thumbnail

STAT+: Medicare Advantage insurers will score $2 billion gift thanks to limited audits

STAT

” But based on a final regulation published Monday, Medicare is going against that public interest by giving a free pass to Medicare Advantage plans for any erroneous codes they submitted between 2011 and 2017. The amount of taxpayer money that insurers will get to keep because of that decision: $2 billion.

285
285